RecruitingNCT03848052
Evolution of the Therapeutic Care in Lung Cancer in France Since 2015 (ESME LC)
Epidemiological Strategy and Medical Economic (ESME) Research Program / Academic Real World Data Platform: Evolution of the Therapeutic Care in Lung Cancer in France Since 2015
Sponsor
UNICANCER
Enrollment
70,000 participants
Start Date
Oct 2, 2017
Study Type
OBSERVATIONAL
Conditions
Summary
This database compiles data from existing data available from patient's electronic medical records (EMR) at the 38 participating hospitals (20 French comprehensive cancer centers and 18 public hospitals).
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Adult (over 18)
- Treated (with radiotherapy or systemic anti-cancer treatment) for a lung cancer or diagnosed with metastatic lung cancer over the selection period at one of the participating site
Exclusion Criteria1
- \- None
Locations(21)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03848052
Related Trials
Virtual Agent Feasibility in Oncology Patients (NTT Data)
NCT066820131 location
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
NCT046786483 locations
Mid-transverse Process Combined With Erector Spinae Block Versus Paravertebral Plane Block
NCT066185991 location
Empathic Communication Skills (ECS) Training
NCT0545684112 locations
Rhomboid Intercostal Block vs Erector Spinae Block
NCT070406181 location